🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

IAS - Tunisia Kick off call . Meeting with colleagues in University of Tunis Al-Manar , Dr Dr. Amani Kallel , President of Tunisian Atherosclerosis Society and her team to discuss how to establish the first lipid clinic in Tunisia . Together, we can CHANGE . International Atherosclerosis Society (IAS) .

Last but certainly not least, the last Regional Federation of this series - Asia-Pacific. Regional Federations help IAS by promoting and supporting the development of research programs, scientists and the next generation of ASCVD experts in their respective regions. This group

IAS in collaboration with the National Heart Hospital in Lusaka, Zambia, arranged the first ever #FH symposium to staff a division of internal medicine. IAS board member Mutaz Al-Sabah spoke with department team members to learn how to diagnose and treat this genetic lipid

📹‼️NEW video series‼️📹 IAS released a video series with experts Peter Libby, MD, Michael Miller, MD, and Viviane Z. Rocha, MD (Viviane Zorzanelli Rocha), about #hypertriglyceridemia, its health implications and therapeutic options for optimal management of patients. Watch all 3 videos in

Former Wael fellowship winner Youmna Ghaleb, MD, shares her experience from the program in 2020. "This experience greatly enhanced my expertise and opened new research opportunities." The 7th Wael Almahmeed (Dr. Wael AlMahmeed) and IAS Research Training Fellowship is designed to support

The Brussels International Declaration on Lp(a), endorsed by IAS, delivers an ambitious, five-year global strategy to make Lp(a) testing routine and ensure equitable management across populations. Read more in FH Europe Foundation's paper: bit.ly/4dLB4GW

Join ECPD for its International Summer School on Cardiovascular Diseases on June 18-21, 2025, in Budva, Montenegro. The program will focus on the latest research, technological advances and case study reviews, as well as discussions on the guidelines and latest treatment options

Join IAS at a joint symposium with the Japan Atherosclerosis Society for its 57th Annual Scientific Meeting on July 5, 2025, in Tsukuba, Japan. This event aims to shape the future of atherosclerosis research from vascular systems to organ pathophysiology. Learn more:

⁉️Have you registered for ICoLA 2025 in Seoul, South Korea? 📝Abstract submission will be closed on June 18. ✅Learn more, register and submit your abstracts NOW: bit.ly/43893pu

Watch 2022 Wael Research Fellowship winner Carine Ayoub, PharmD, PhD, shares her experience while in the program and how the grant has helped transform her career. Learn more & apply today for the 7th Wael Almahmeed and IAS Research Training Fellowships: bit.ly/3Pkq34m

IAS is going to be at Sodocardio's 30th Dominican Congress of Cardiology 2025, on June 19 – 22, 2025 at the Hard Rock Hotel Convention Center in Punta Cana. If you're around and want to meet up, reach out! Learn more: bit.ly/45ZH2C9

Are you interested in becoming a scientific leader in inflammation and cardiometabolic disease? Apply today to be in the first cohort of the IAS Inflammation Academy. The year-long program will begin with a one-day session in Madrid, Spain on August 28. Travel stipend available

Former Wael fellowship winner Amirhossein Sahbkar, MD, shares his experience from the program in 2022. "The mentorship and support I received through the IAS community have been invaluable, guiding me in navigating the complexities of cardiovascular research." #DYK? Selected

📍IAS will be at the 30th Dominican Congress of Cardiology 2025, hosted by @SODOCARDIO, at the Hard Rock Hotel Convention Center in Punta Cana! 🇩🇴 ✨ Don’t miss the first-ever IAS/SODOCARDIO joint session on lipids in Dominican Republic! International Atherosclerosis Society (IAS) bit.ly/45ZH2C9

Thank you to Dra Máxima Mendez, Rodrigo Alonso Karlezi (Rodrigo Alonso Karlezi), Alberto J. Lorenzatti, MD, MTFAC, FACC, and Vivencio Barrios for their extraordinary presentations about the management of atherosclerosis. It's wonderful to see so many of IAS' experts involved in the

#DYK? Current therapeutic agents for patients living with #PersistentChylomicronemia are generally ineffective. But a new first-in-class agent was tested in the PALISADE study. Learn more: bit.ly/4kWgVkX

On June 18, IAS had a joint session at the ECPD International Summer School on Cardiovascular Diseases. IAS' Regional Federation Europe was well represented at the event. Chair Michal Vrablik, MD, PhD, presented on the advances in the European prevention of cardiovascular

Atherosclerotic plaques develop in large- and medium-sized arteries in places with disturbed blood flow, such as branch points or curves. Read more in IAS' white paper, "Assessment & Treatment of Inflammation in Atherosclerosis:" bit.ly/4fh2Hbl

Are you interested in becoming a scientific leader in inflammation and cardiometabolic disease? 👨‍🔬 👩‍🔬 🥼 Apply today to be in the first cohort of the IAS Inflammation Academy. The year-long program will begin with a one-day session in Madrid, Spain on August 28. Travel stipend

"Although atherosclerosis and cardio-metabolic disease are universal problems, there may be significant regional differences in risk factors and clinical expression. Similarly, locally tailored strategies are necessary to effectively combat these diseases. This requires all